For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $59.22 in the prior trading day, Incyte Corp (NASDAQ: INCY) closed at $58.46, down -1.28%. In other words, the price has decreased by -$1.28 from its previous closing price. On the day, 1.48 million shares were traded. INCY stock price reached its highest trading level at $59.94 during the session, while it also had its lowest trading level at $58.22.
Ratios:
Our goal is to gain a better understanding of INCY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 45.42. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 1.97. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On December 17, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $77.UBS initiated its Neutral rating on December 17, 2024, with a $77 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 14 ’25 when Flannelly Barry P sold 19,807 shares for $67.69 per share. The transaction valued at 1,340,656 led to the insider holds 33,567 shares of the business.
BARRY FLANNELLY bought 19,807 shares of INCY for $1,340,728 on Mar 14 ’25. On Mar 04 ’25, another insider, Denton Sheila A., who serves as the EVP & General Counsel of the company, sold 599 shares for $69.99 each. As a result, the insider received 41,924 and left with 25,848 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INCY now has a Market Capitalization of 11313413120 and an Enterprise Value of 9215678464. As of this moment, Incyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 215.56, and their Forward P/E ratio for the next fiscal year is 9.04. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.67 while its Price-to-Book (P/B) ratio in mrq is 3.28. Its current Enterprise Value per Revenue stands at 2.173 whereas that against EBITDA is 51.891.
Stock Price History:
The Beta on a monthly basis for INCY is 0.68, which has changed by 0.10887706 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, INCY has reached a high of $83.95, while it has fallen to a 52-week low of $50.35. The 50-Day Moving Average of the stock is -11.82%, while the 200-Day Moving Average is calculated to be -13.64%.
Shares Statistics:
The stock has traded on average 1.95M shares per day over the past 3-months and 2524890 shares per day over the last 10 days, according to various share statistics. A total of 193.43M shares are outstanding, with a floating share count of 190.50M. Insiders hold about 1.56% of the company’s shares, while institutions hold 95.72% stake in the company. Shares short for INCY as of 1743379200 were 7190582 with a Short Ratio of 3.69, compared to 1740700800 on 5846755. Therefore, it implies a Short% of Shares Outstanding of 7190582 and a Short% of Float of 6.5799996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
